Organisation paid for research Program year 2023 Source: CMS Open Payments

Endocrine Ips, PLLC

Neither a doctor nor a teaching hospital

Research payments

$1,646,132

1,823 payments

Through program year 2023, Endocrine Ips, PLLC is reported as receiving $1,646,132 in research payments, across 1,823 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$67,641	8
2022	Research	$621,962	621
2021	Research	$863,836	1,177
2020	Research	$11,548	5
2019	Research	$81,146	12

Breakdown

Who paid Research payments · program years 2019–2023

Novo Nordisk AS $931,829 1,728 payments
CSL Behring $633,158 83 payments
AbbVie, Inc. $69,619 11 payments
Amarin Pharma Inc. $11,527 1 payment

Studies the money was for Research payments · program years 2019–2023

A Phase 2a, Double-blind, Randomized, Placebo-controlled, Proof of Concept Study of Vascular Endothelial Growth Factor (VEGF)-B Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease $633,158 83 payments
Nn1436-4625 $335,585 836 payments
Ex9536-4388 $306,379 158 payments
Nn1436-4478 $237,497 521 payments
M16-100 $69,619 11 payments
Nn9838-4862 $47,442 141 payments
A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the effect of AMR101 on Cardiovascular Heath and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardio $11,527 1 payment
Nn6435-4697 $4,925 72 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.